1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on July 13, 2025

The Smartest Dividend Stocks to Buy With $300 Right Now
ABBV

Motley Fool

a day ago

The Smartest Dividend Stocks to Buy With $300 Right Now

Refresh Releases First of its Kind Eye Drop for Dry Eyes
ABBV

CNW Group

a day ago

Refresh Releases First of its Kind Eye Drop for Dry Eyes

ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?
ABBV

Zacks

2 days ago

ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?

IGI and AbbVie sign licence deal for cancer and autoimmune therapy
ABBV

Pharmaceutical Technology

2 days ago

IGI and AbbVie sign licence deal for cancer and autoimmune therapy

Ulcerative Colitis Drug Market Analysis and Forecast, 2025-2035 | Anti-TNF a Agents and Interleukin Antagonists Spearhead Therapeutic Developments
ABBV

GlobeNewswire

2 days ago

Ulcerative Colitis Drug Market Analysis and Forecast, 2025-2035 | Anti-TNF a Agents and Interleukin Antagonists Spearhead Therapeutic Developments

Psoriatic Arthritis Market Report 2025-2035 | Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma
ABBV

GlobeNewswire

2 days ago

Psoriatic Arthritis Market Report 2025-2035 | Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma

What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
ABBV

Motley Fool

2 days ago

What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill

AbbVie (ABBV) Laps the Stock Market: Here's Why
ABBV

Zacks

2 days ago

AbbVie (ABBV) Laps the Stock Market: Here's Why

Wall Street Stunned: AbbVie Drops $700M on a Little-Known Indian Cancer Drug
ABBV

GuruFocus.com

3 days ago

Wall Street Stunned: AbbVie Drops $700M on a Little-Known Indian Cancer Drug

AbbVie Inc. (ABBV): A Bull Case Theory
ABBV

Insider Monkey

3 days ago

AbbVie Inc. (ABBV): A Bull Case Theory

Tesla robotaxi, AbbVie licenses Glenmark cancer drug, McDonald's
ABBV

Yahoo Finance Video

3 days ago

Tesla robotaxi, AbbVie licenses Glenmark cancer drug, McDonald's

ABBV

MT Newswires

3 days ago

AbbVie Signs Deal to License IGI Therapeutics' ISB 2001 Antibody for Up to $1.93 Billion Plus Royalties

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
ABBV

GlobeNewswire

3 days ago

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
ABBV

PR Newswire

3 days ago

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

Morgan Stanley Maintained an Overweight Rating on AbbVie (ABBV)
ABBV

Insider Monkey

4 days ago

Morgan Stanley Maintained an Overweight Rating on AbbVie (ABBV)

Stock market today: Dow, S&P 500 slip as Trump stays firm on August tariff deadline, announces copper duties
ABBV

Yahoo Finance

4 days ago

Stock market today: Dow, S&P 500 slip as Trump stays firm on August tariff deadline, announces copper duties

Uber's highs, Trump tariff warning, Wendy’s CEO heads to Hershey
ABBV

Yahoo Finance Video

5 days ago

Uber's highs, Trump tariff warning, Wendy’s CEO heads to Hershey

Nocturia Market Research and Forecast Report 2025-2034, Featuring Leading Players - Urigen Pharmaceuticals, Glenmark Pharmaceuticals, AbbVie, Teva Pharmaceuticals
ABBV

GlobeNewswire

5 days ago

Nocturia Market Research and Forecast Report 2025-2034, Featuring Leading Players - Urigen Pharmaceuticals, Glenmark Pharmaceuticals, AbbVie, Teva Pharmaceuticals

How Will Skyrizi and Rinvoq Sales Aid AbbVie's Upcoming Q2 Results?
ABBV

Zacks

5 days ago

How Will Skyrizi and Rinvoq Sales Aid AbbVie's Upcoming Q2 Results?

AbbVie to Acquire Capstan Therapeutics for $2.1B, Boosting Autoimmune Pipeline
ABBV

Insider Monkey

5 days ago

AbbVie to Acquire Capstan Therapeutics for $2.1B, Boosting Autoimmune Pipeline

Is biopharma dealmaking getting hot again?
ABBV

Pharma Voice

5 days ago

Is biopharma dealmaking getting hot again?

ABBV

Investing.com

6 days ago

Prime Medicine stock soars amid gene editing sector momentum

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
ABBV

Zacks

6 days ago

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It

Here's What to Expect From AbbVie's Next Earnings Report
ABBV

Barchart

6 days ago

Here's What to Expect From AbbVie's Next Earnings Report

3 No-Brainer Stocks to Buy in July
ABBV

Motley Fool

6 days ago

3 No-Brainer Stocks to Buy in July

2 Dividend Stocks to Buy for Decades of Passive Income
ABBV

Motley Fool

7 days ago

2 Dividend Stocks to Buy for Decades of Passive Income

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
ABBV

Motley Fool

8 days ago

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?
ABBV

Zacks

10 days ago

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth
ABBV

Zacks

10 days ago

Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth

3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now
ABBV

Barchart

10 days ago

3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now

The Zacks Analyst Blog Highlights Alphabet, AbbVie and The Walt Disney
ABBV

Zacks

11 days ago

The Zacks Analyst Blog Highlights Alphabet, AbbVie and The Walt Disney

Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
ABBV

Zacks

11 days ago

Why AbbVie (ABBV) is a Top Value Stock for the Long-Term

Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?
ABBV

Zacks

11 days ago

Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?

Will AbbVie's Acquisition Spree Aid Pipeline Growth?
ABBV

Zacks

11 days ago

Will AbbVie's Acquisition Spree Aid Pipeline Growth?

Exploring 3 High Growth Tech Stocks In The US Market
ABBV

Simply Wall St.

11 days ago

Exploring 3 High Growth Tech Stocks In The US Market

Top Stock Reports for Alphabet, AbbVie & Walt Disney
ABBV

Zacks

11 days ago

Top Stock Reports for Alphabet, AbbVie & Walt Disney

ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B
ABBV

Zacks

12 days ago

ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
ABBV

Zacks

12 days ago

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

ABBV

MT Newswires

12 days ago

Sector Update: Health Care Stocks Higher Late Afternoon

ABBV

MT Newswires

13 days ago

Sector Update: Health Care Stocks Advance Monday Afternoon

ABBV

MT Newswires

13 days ago

Top Midday Stories: Hewlett Packard, Juniper Settle Antitrust Suit With DOJ; Home Depot Unit Acquires GMS for $5.5 Billion

Stocks See Support as Signs of Trade Progress Boost Market Sentiment
ABBV

Barchart

13 days ago

Stocks See Support as Signs of Trade Progress Boost Market Sentiment

AbbVie Agrees to Acquire Capstan Therapeutics for $2.1 Billion
ABBV

The Wall Street Journal

13 days ago

AbbVie Agrees to Acquire Capstan Therapeutics for $2.1 Billion

ABBV

MT Newswires

13 days ago

AbbVie Unit Allergan Says US FDA Accepts For Review Premarket Approval Application For Intradermal Injection

ABBV

MT Newswires

13 days ago

AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion

3 Dividend Stocks to Double Up on Right Now
ABBV

Motley Fool

14 days ago

3 Dividend Stocks to Double Up on Right Now

Those who invested in AbbVie (NYSE:ABBV) five years ago are up 126%
ABBV

Simply Wall St.

15 days ago

Those who invested in AbbVie (NYSE:ABBV) five years ago are up 126%

Got $500? 2 Healthcare Stocks to Buy and Hold Forever
ABBV

Motley Fool

15 days ago

Got $500? 2 Healthcare Stocks to Buy and Hold Forever

AbbVie’s Elahere Market Expected to Skyrocket to $6B by 2034 in Ovarian Cancer Treatment
ABBV

Insider Monkey

15 days ago

AbbVie’s Elahere Market Expected to Skyrocket to $6B by 2034 in Ovarian Cancer Treatment

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
ABBV

Zacks

15 days ago

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts

AbbVie Adds More Than $24B in 6 Months: How to Play ABBV Stock
ABBV

Zacks

16 days ago

AbbVie Adds More Than $24B in 6 Months: How to Play ABBV Stock

Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?
ABBV

Investor's Business Daily

16 days ago

Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?

Here's Why AbbVie (ABBV) is a Strong Momentum Stock
ABBV

Zacks

17 days ago

Here's Why AbbVie (ABBV) is a Strong Momentum Stock

Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes
ABBV

Investor's Business Daily

17 days ago

Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes

Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer
ABBV

PR Newswire

18 days ago

Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer

Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer
ABBV

GlobeNewswire

18 days ago

Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer

AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial
ABBV

Insider Monkey

18 days ago

AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
ABBV

Zacks

19 days ago

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?
ABBV

Zacks

19 days ago

Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?

Age-Related Vision Dysfunction Market Research 2025-2035 | Kodiak Sciences, Genentech, and AbbVie Drive Innovations Through Advanced, Sustainable Solutions
ABBV

GlobeNewswire

19 days ago

Age-Related Vision Dysfunction Market Research 2025-2035 | Kodiak Sciences, Genentech, and AbbVie Drive Innovations Through Advanced, Sustainable Solutions

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications
ABBV

Zacks

20 days ago

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications

Is AbbVie the Best Dividend Stock in Big Pharma Today?
ABBV

Insider Monkey

22 days ago

Is AbbVie the Best Dividend Stock in Big Pharma Today?

LLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?
ABBV

Zacks

23 days ago

LLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?

ABBV

PR Newswire

23 days ago

AbbVie Declares Quarterly Dividend

AbbVie’s Phase III trial of atogepant for migraine meets primary goal
ABBV

Clinical Trials Arena

24 days ago

AbbVie’s Phase III trial of atogepant for migraine meets primary goal

AbbVie (NYSE:ABBV) Announces Positive Phase 3 Results for Migraine Drug Atogepant
ABBV

Simply Wall St.

25 days ago

AbbVie (NYSE:ABBV) Announces Positive Phase 3 Results for Migraine Drug Atogepant

GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?
ABBV

Zacks

25 days ago

GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?

ABBV

MT Newswires

25 days ago

AbbVie's Phase 3 Study of Atogepant in Migraine Prevention Achieves Primary, Secondary Endpoints

ABBV

PR Newswire

25 days ago

AbbVie Announces New Data Demonstrating Atogepant (QULIPTA® / AQUIPTA®) Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine Prevention

AbbVie says Phase 3 Verona trial of venetoclax/azacitidine did not meet endpoint
ABBV

TipRanks

a month ago

AbbVie says Phase 3 Verona trial of venetoclax/azacitidine did not meet endpoint

AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C
ABBV

Insider Monkey

a month ago

AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C

AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics
ABBV

Insider Monkey

a month ago

AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics

ABBV

MT Newswires

a month ago

Sector Update: Health Care Stocks Retreat Late Afternoon

ABBV

MT Newswires

a month ago

Sector Update: Health Care

ABBV

Clinical Trials Arena

a month ago

EHA 2025: Genmab and AbbVie’s Epkinly outpaces BiTE rivals in r/r DLBCL trial

Here's Why AbbVie (ABBV) is a Strong Value Stock
ABBV

Zacks

a month ago

Here's Why AbbVie (ABBV) is a Strong Value Stock

ABBV

MT Newswires

a month ago

AbbVie Says Myelodysplastic Syndrome Phase 3 Trial Failed to Meet Primary Endpoint

ABBV

PR Newswire

a month ago

AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes

1 Cash-Producing Stock for Long-Term Investors and 2 to Steer Clear Of
ABBV

StockStory

a month ago

1 Cash-Producing Stock for Long-Term Investors and 2 to Steer Clear Of

AbbVie Secures FDA Approval to Expand Mavyret’s Label
ABBV

Insider Monkey

a month ago

AbbVie Secures FDA Approval to Expand Mavyret’s Label

FDA approves label expansion of AbbVie hepatitis C therapy
ABBV

Pharmaceutical Technology

a month ago

FDA approves label expansion of AbbVie hepatitis C therapy

Senators Propose Ban on Drug Advertising to Consumers
ABBV

The Wall Street Journal

a month ago

Senators Propose Ban on Drug Advertising to Consumers

ABBV

Investing.com

a month ago

Lawmakers push to ban direct-to-consumer drug advertising, WSJ reports

AbbVie (NYSE:ABBV) Achieves FDA Approval for MAVYRET Label Expansion to Treat Pediatric Hepatitis C
ABBV

Simply Wall St.

a month ago

AbbVie (NYSE:ABBV) Achieves FDA Approval for MAVYRET Label Expansion to Treat Pediatric Hepatitis C

AbbVie (ABBV) Gains As Market Dips: What You Should Know
ABBV

Zacks

a month ago

AbbVie (ABBV) Gains As Market Dips: What You Should Know

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)
ABBV

Benzinga

a month ago

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)

ABBV

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

ABBV

MT Newswires

a month ago

AbbVie Receives FDA Label Expansion Approval for Mavyret to Treat Hepatitis C

U.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus
ABBV

PR Newswire

a month ago

U.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
ABBV

Zacks

a month ago

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?
ABBV

Zacks

a month ago

Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of
ABBV

StockStory

a month ago

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of

3 Stocks With Mouthwatering Dividends You Can Buy Right Now
ABBV

Motley Fool

a month ago

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

Challenges pharma companies face in push into US manufacturing
ABBV

Yahoo Finance Video

a month ago

Challenges pharma companies face in push into US manufacturing

Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?
ABBV

Zacks

a month ago

Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?

AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
ABBV

Zacks

a month ago

AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
ABBV

Motley Fool

a month ago

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks

AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?
ABBV

StockStory

a month ago

AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?

Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
ABBV

Zacks

a month ago

Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks

3 Cheap Dividend Growth Stocks to Buy Right Now
ABBV

Motley Fool

a month ago

3 Cheap Dividend Growth Stocks to Buy Right Now

Share on Social Networks: